{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T16:41:14Z","timestamp":1792341674544,"version":"4.4.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Cervical cancer, primarily caused by high-risk human papillomavirus (HR-HPV), remains one of the leading causes of cancer-related death in women globally. No nationwide analysis has integrated molecular HPV testing and cervical cytology using registry-based data. The aim of the present study was to provide the first nationwide registry-based estimate of HR-HPV positivity and age-specific cervical cytological abnormalities within the Chilean National Cervical Cancer Screening Program. A retrospective descriptive analysis was conducted using nationwide aggregate data from the Chilean Ministry of Health (MINSAL), covering the nationwide cervical cancer screening network. A total of 506 712 cervical samples tested for HR-HPV (2020\u20132024) and 4 055 738 adequate Papanicolaou (PAP) tests (2019\u20132024) were analyzed. The HR-HPV positivity between 2020 and 2024 was 13.02% (95% confidence interval: 12.93\u201313.11%), with annual values of 12.34, 12.73, 13.27, 13.47, and 12.85% in 2020, 2021, 2022, 2023, and 2024, respectively. The highest HPV prevalence was observed in G1 (30\u201344 years), ranging from 15.39 to 16.26%, compared with 8.95\u201310.55% in G2 (45\u201364 years) and 5.46\u201313.30% in G3 (\u226565 years). Among all HPV-positive women, HPV-16 accounted for 19.57% of infections, HPV-18 for 6.39%, and pooled HR-HPV types for 74.03%. Regarding PAP results, 95.63% of adequate tests were classified as negative for intraepithelial lesion or malignancy, while low-grade squamous intraepithelial lesion (LSIL) (NIE I) was found in 0.77%, high-grade squamous intraepithelial lesion (HSIL) (NIE II) in 0.33%, and severe HSIL (NIE III) in 0.26% of cases. This nationwide registry-based study establishes the first comprehensive baseline of HR-HPV positivity and cervical cytology in Chile. The predominance of non-16\/18\u2005h-HPV infections reinforces the importance of broad-spectrum extended HPV genotyping surveillance and provides a benchmark for evaluating the long-term impact of HPV vaccination and implementation of primary HPV screening.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cej.0000000000001042","type":"journal-article","created":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T16:00:08Z","timestamp":1792339208000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Nationwide prevalence of high-risk human papillomavirus and cervical cytology findings in Chile: a registry-based study (2019\u20132024)"],"prefix":"10.1097","author":[{"given":"Haylyn","family":"Sarria","sequence":"first","affiliation":[{"name":"Department of Public Health, Regional Ministry of Health"},{"name":"Midwifery Program, Faculty of Medicine and Health Sciences, Universidad Central de Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliano","family":"Bernal","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular and Cellular Biology of Cancer, C\u00e1ncerLab, Department of Biomedical Sciences, Faculty of Medicine, Universidad Cat\u00f3lica del Norte, Coquimbo, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"key":"R1-20261018","doi-asserted-by":"crossref","first-page":"102913","DOI":"10.1016\/j.canep.2025.102913","article-title":"Prevalence of human papillomavirus in Arica and Antofagasta, in the North of Chile.","volume":"99","author":"Acu\u00f1a","year":"2025","journal-title":"Cancer Epidemiol"},{"key":"R2-20261018","first-page":"1543","article-title":"Prevalence of HPV subtypes 16 and 18 among Yemeni patients with cervical cancer.","volume":"18","author":"Ahmed","year":"2017","journal-title":"Asian Pac J Cancer Prev"},{"key":"R3-20261018","doi-asserted-by":"crossref","first-page":"e0008123","DOI":"10.1128\/spectrum.00081-23","article-title":"Comparison between the Roche Cobas 4800 HPV, Abbott RealTime High-Risk HPV, Seegene Anyplex II HPV28, and Novel Seegene Allplex HPV28 Assays.","volume":"11","author":"Bell","year":"2023","journal-title":"Microbiol Spectr"},{"key":"R4-20261018","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1086\/657321","article-title":"Cervical HPV prevalence in 5 continents: meta-analysis of 1 million women.","volume":"202","author":"Bruni","year":"2010","journal-title":"J Infect Dis"},{"key":"R5-20261018","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.semradonc.2021.02.006","article-title":"Biology of HPV mediated carcinogenesis and tumor progression.","volume":"31","author":"Cosper","year":"2021","journal-title":"Semin Radiat Oncol"},{"key":"R6-20261018","doi-asserted-by":"crossref","first-page":"102757","DOI":"10.1016\/j.canep.2025.102757","article-title":"Prevalence of human papilloma virus in Coquimbo, Chile.","volume":"95","author":"Farias","year":"2025","journal-title":"Cancer Epidemiol"},{"key":"R7-20261018","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.26633\/RPSP.2024.128","article-title":"High frequency of HPV high-risk preventable genotypes in Ecuadorian women with invasive cervical cancer.","volume":"48","author":"Garc\u00eda Muentes","year":"2024","journal-title":"Rev Panam Salud Publica"},{"key":"R10-20261018","doi-asserted-by":"crossref","first-page":"102435","DOI":"10.1016\/j.canep.2023.102435","article-title":"Latin American and the Caribbean Code Against Cancer 1st edition: infections and cancer.","volume":"86","author":"Herrero","year":"2023","journal-title":"Cancer Epidemiol"},{"key":"R11-20261018","doi-asserted-by":"crossref","first-page":"22014","DOI":"10.1038\/s41598-024-73317-8","article-title":"Cervical cancer microbiome analysis: comparing HPV 16 and 18 with other HPV types.","volume":"14","author":"Hidjo","year":"2024","journal-title":"Sci Rep"},{"key":"R14-20261018","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ijc.20244","article-title":"Against which human papillomavirus types shall we vaccinate and screen?","volume":"111","author":"Mu\u00f1oz","year":"2004","journal-title":"Int J Cancer"},{"key":"R16-20261018","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1038\/s41598-025-34501-6","article-title":"Age distribution of high-risk HPV infection and cervical lesions in an unvaccinated adult Brazilian population within an organized screening program.","volume":"16","author":"Rego","year":"2026","journal-title":"Sci Rep"},{"key":"R17-20261018","doi-asserted-by":"crossref","first-page":"e29190","DOI":"10.1002\/jmv.29190","article-title":"Prevalence and genotype distribution of HPV in cervical adenocarcinoma: a meta-analysis.","volume":"95","author":"Reynders","year":"2023","journal-title":"J Med Virol"},{"key":"R18-20261018","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","article-title":"Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis.","volume":"7","author":"de Sanjos\u00e9","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"R19-20261018","doi-asserted-by":"crossref","first-page":"117451","DOI":"10.1016\/j.diagmicrobio.2026.117451","article-title":"Prevalence of HPV in the public health system of the central-northern region of Chile.","volume":"116","author":"Sarria","year":"2026","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R20-20261018","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.semradonc.2021.04.001","article-title":"Epidemiology of HPV related malignancies.","volume":"31","author":"Scott-Wittenborn","year":"2021","journal-title":"Semin Radiat Oncol"},{"key":"R21-20261018","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1038\/s41591-023-02600-4","article-title":"Benefits, harms and cost-effectiveness of cervical screening strategies.","volume":"29","author":"Simms","year":"2023","journal-title":"Nat Med"},{"key":"R22-20261018","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4067\/s0716-10182024000100020","article-title":"Distribuci\u00f3n de genotipos de VPH de alto riesgo en la Regi\u00f3n Metropolitana, Chile.","volume":"41","author":"Tapia","year":"2024","journal-title":"Rev Chil Infect"},{"key":"R23-20261018","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/jmv.24805","article-title":"Prevalence of HPV infection among Chilean women from 2012 to 2016.","volume":"89","author":"Vergara","year":"2017","journal-title":"J Med Virol"},{"key":"R25-20261018","doi-asserted-by":"crossref","first-page":"e35736","DOI":"10.1016\/j.heliyon.2024.e35736","article-title":"Patterns of single and multiple HPV infections in female: a systematic review and meta-analysis.","volume":"10","author":"Zhou","year":"2024","journal-title":"Heliyon"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CEJ.0000000000001042","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T16:00:11Z","timestamp":1792339211000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CEJ.0000000000001042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":19,"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000001042","relation":{},"ISSN":["0959-8278","1473-5709"],"issn-type":[{"value":"0959-8278","type":"print"},{"value":"1473-5709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]},"assertion":[{"value":"2026-07-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-31","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}